Damon Runyon
We fund high-risk, high-reward cancer research
Damon Runyon Cancer Research Foundation awards $3.2M to innovative early-career scientists - Honors and Awards
Damon Runyon Cancer Research Foundation awards $3.2M to innovative early-career scientists - Honors and Awards
The Damon Runyon Cancer Research Foundation has announced eight recipients of the 2026 Damon Runyon-Rachleff Innovation Award, established to support high-risk, high-reward ideas with the potential to significantly impact the prevention, diagnosis, or treatment of cancer. Five extraordinary early-career researchers will receive initial grants of $400,000 over two years, and each will have the opportunity to receive two additional years of funding (for a potential total of $800,000).
A potential breakthrough in treating RAS-driven cancers
A potential breakthrough in treating RAS-driven cancers
Cancers caused by mutations in the RAS gene family—which include pancreatic, colorectal, lung, skin, and ovarian cancers, among others—have thwarted drug development efforts for decades.
Creative Ways to Back Young Scientists: Andy Rachleff and Yung Lie on The Long Run - TimmermanReport.com
Creative Ways to Back Young Scientists: Andy Rachleff and Yung Lie on The Long Run - TimmermanReport.com
Yung Lie and Andy Rachleff are today’s guests on The Long Run. Yung is the president and CEO of the Damon Runyon Cancer Research Foundation, based in New York. Andy is the board chair. Andy was one of the founding partners of Benchmark Capital, the prominent Silicon Valley VC firm, and today is the chairman... Read More
Damon Runyon awards $4.2 million to clinical cancer research
Damon Runyon awards $4.2 million to clinical cancer research
The Damon Runyon Cancer Research Foundation has named five new Damon Runyon Clinical Investigators. The recipients of this prestigious award are outstanding, early-career physician-scientists conducting patient-oriented cancer research at major research centers under the mentorship of the nation's leading scientists and clinicians.
Damon Runyon Cancer Research Foundation invests nearly $1.4 million to support physician-scientists
Damon Runyon Cancer Research Foundation invests nearly $1.4 million to support physician-scientists
A new approach to targeted therapy
A new approach to targeted therapy
In cancer treatment, “targeted therapies” refer to drugs that identify and attack specific proteins in cancer cells that help them survive and grow, while leaving normal cells alone. Due to their specificity, targeted therapies tend to be less toxic than chemotherapy or radiation therapies. Often, they take the form of small molecule inhibitors, which bind to the cancer-promoting proteins and disable them. Unfortunately, however, small molecule inhibitors only work for a subset of cancers.
A new explanation for sex differences in cancer
A new explanation for sex differences in cancer
Timmerman Traverse for Damon Runyon Cancer Research Foundation
Timmerman Traverse for Damon Runyon Cancer Research Foundation
Damon Runyon Cancer Research Foundation and St. Jude Children’s Research Hospital invest $1.8 million in childhood cancer research
Damon Runyon Cancer Research Foundation and St. Jude Children’s Research Hospital invest $1.8 million in childhood cancer research
Support Damon Runyon on World Cancer Day
Support Damon Runyon on World Cancer Day
Damon Runyon Cancer Research Foundation awards $3.2M to innovative young scientists
Damon Runyon Cancer Research Foundation awards $3.2M to innovative young scientists
The Damon Runyon Cancer Research Foundation has announced eight recipients of the 2025 Damon Runyon-Rachleff Innovation Award, established to support high-risk, high-reward ideas with the potential to significantly impact the prevention, diagnosis, or treatment of cancer. Five extraordinary early-career researchers will receive initial grants of $400,000 over two years, and each will have the opportunity to receive two additional years of funding (for a potential total of $800,000).
All gifts of any size fully matched between now and midnight! Donate today.
All gifts of any size fully matched between now and midnight! Donate today.
Slowing the clock on aging stem cells
Slowing the clock on aging stem cells
Blood stem cells, like all living things, lose their regenerative capacity with age. Because blood stem cells generate not only blood but all the cells in our immune system, age-related dysfunction can lead to a plethora of systemic issues in older adults, including blood cancer. There is, of course, no stopping time. But according to a new study from researchers at the Columbia Stem Cell Initiative, including Damon Runyon Fellow James Swann, VetMB, DPhil, there may be a way to slow down the clock.
One man’s mission to revive a forgotten, life-saving cancer drug
One man’s mission to revive a forgotten, life-saving cancer drug
Jake’s Story - The Jake Wetchler Foundation
Jake’s Story - The Jake Wetchler Foundation
The Jake Wetchler Foundation is founded in remembrance of our son, Jake, and all children fighting against cancer. Jake had Hodgkin's lymphoma disease but lost his life to Acute Myeloid Leukemia. Even though Jake did not survive, his ideals inspired us to continue the fight. Learn about his story.
Damon Runyon Cancer Research Foundation awards $4.8 million to exceptional early-career scientists
Damon Runyon Cancer Research Foundation awards $4.8 million to exceptional early-career scientists
Damon Runyon Cancer Research Foundation awards $5.2 million to top clinical investigators
Damon Runyon Cancer Research Foundation awards $5.2 million to top clinical investigators
New blood test to detect aggressive form of prostate cancer
New blood test to detect aggressive form of prostate cancer
Prostate cancer is a disease with many subtypes, some of which are more difficult to treat than others. While most prostate cancer cells rely on androgen hormones to grow—allowing androgen blockers to emerge as an effective therapy—15 to 20 percent of prostate cancers evolve to be “androgen-independent.” One such subtype is known as castration-resistant neuroendocrine prostate cancer (CRPC-NE), for which chemotherapy is the primary treatment strategy.
Damon Runyon announces inaugural class of SPARK Scholars
Damon Runyon announces inaugural class of SPARK Scholars
The Damon Runyon Cancer Research Foundation has named the first cohort of the Damon Runyon Scholars Program for Advancing Research and Knowledge (SPARK), a one-year intensive cancer research internship program for post-baccalaureate students who come from varied backgrounds. The goal of the program is to provide young trainees who have the potential to become leaders in cancer research with rigorous scientific training and a network of mentors and peers to support their next steps into graduate school and beyond.
“Virtual biopsy” may transform how we diagnose skin cancer
“Virtual biopsy” may transform how we diagnose skin cancer
A tissue biopsy, in which a section of skin is surgically removed for microscopic evaluation, has long been the most effective means of diagnosing skin cancer. But biopsies are invasive and time-consuming procedures, with patients often waiting days for results, developing scars, or forgoing biopsy altogether and opting to “wait and see.” Given that one in five Americans will develop skin cancer in their lifetime, this is a dilemma many of us have experienced firsthand.
Damon Runyon Cancer Research Foundation announces four recipients of 2024 Physician-Scientist Training Award
Damon Runyon Cancer Research Foundation announces four recipients of 2024 Physician-Scientist Training Award
Get Involved | Damon Runyon
Get Involved | Damon Runyon
Damon Runyon Cancer Research Foundation awards $3.2M to innovative early-career scientists
Damon Runyon Cancer Research Foundation awards $3.2M to innovative early-career scientists
2024 Timmerman Traverse raises over $1M for cancer research
2024 Timmerman Traverse raises over $1M for cancer research
Inaugural class of Damon Runyon–St. Jude Pediatric Cancer Research Fellows announced
Inaugural class of Damon Runyon–St. Jude Pediatric Cancer Research Fellows announced
Damon Runyon launches SPARK post-baccalaureate research internship
Damon Runyon launches SPARK post-baccalaureate research internship
Make a gift
Make a gift
Reviving an old hypothesis about chromosomes and cancer
Reviving an old hypothesis about chromosomes and cancer
Potential new targeted therapy for a rare but lethal cancer
Potential new targeted therapy for a rare but lethal cancer
Early immunotherapy drug shows new promise against glioblastoma in mice
Early immunotherapy drug shows new promise against glioblastoma in mice
A “MAJESTIC” new way to engineer CAR T cells
A “MAJESTIC” new way to engineer CAR T cells
2024 Timmerman Traverse to benefit Damon Runyon’s cancer researchers
2024 Timmerman Traverse to benefit Damon Runyon’s cancer researchers
Damon Runyon Cancer Research Foundation awards $3.9 million to exceptional early-career scientists
Damon Runyon Cancer Research Foundation awards $3.9 million to exceptional early-career scientists
Two new clinical trials offer hope for brain cancer patients
Two new clinical trials offer hope for brain cancer patients
A new way to visualize antibody-virus data
A new way to visualize antibody-virus data
Stipend Increase
Stipend Increase
Kelly L. Bolton, MD, PhD
Kelly L. Bolton, MD, PhD
2023 Physician-Scientist Training Award
2023 Physician-Scientist Training Award
2023 Damon Runyon 5K at Yankee Stadium
2023 Damon Runyon 5K at Yankee Stadium
Damon Runyon–St. Jude Pediatric Cancer Research Fellowship
Damon Runyon–St. Jude Pediatric Cancer Research Fellowship
New immunotherapy-enhancing drug is making its way to the clinic
New immunotherapy-enhancing drug is making its way to the clinic
New discoveries support the idea that boosting the p53 gene may suppress pancreatic tumor growth
New discoveries support the idea that boosting the p53 gene may suppress pancreatic tumor growth
Exciting new research on glioblastomas
Exciting new research on glioblastomas
Support Damon Runyon
Support Damon Runyon
AmazonSmile: You shop. Amazon gives.
AmazonSmile: You shop. Amazon gives.
The work of generations: how a Nobel Prize is won
The work of generations: how a Nobel Prize is won
Support Damon Runyon on Amazon Smile
Support Damon Runyon on Amazon Smile
Click for more news!
Click for more news!
View on mobile
Explore other Linktrees
Newt
@newton
straycats
@straycats
rachelscanlon
@rachelscanlon
Melissa Becraft
@melissabecraft
Jenn Leuke
@jenneatsgoood
Popcast
@popcast
Billie Eilish
@billieeilish
morepurposepod
@morepurposepod
Sabrina Carpenter
@sabrinacarpenter
breakingrust
@breakingrust
previous
next
Discover more
See all
@spacesarchitects.ka
@Memeros
@beautifullifewithlaura
@pollyeloquent
@lesaloninfeim
@imonilidelsole
@rutamanglares
@StarKata
@emmasmagicaltravel
@kerupukrenya
@galswhogig.liverpool
@sobrevivientesargentina
@d.collinsmusic
@virbacmexico
@PoluxAlquimia
@currentaffection
@delettucebear
@at99foods
@Jamisonandbexley
@MrKB7
@nurhafizah.mppumk
@asociacionasaeca
@sophie_rain_
@Gbzinxs
@elovcookiesandco
@Lizmartinss
@Rioplaystationmaster
@flore.recife
@tomaeng
@thesunco
@metalmadtv
@losingdaysband
@forthediaries
@houseofmoonco
@dianalauratrejoe
@studivance
@dariqna
@agap2pt
@SalonVici
@carrinho.da.web
@wholebodyempowerment
@Faridxzz
@djchui
@23joyy
@whitewolvesespor